|
Welcome to www.futuremedicine.com - your gateway to objective and authoritative information on medical advances in the post-genomic era, delivering concise, forward-looking perspectives on the scientific, clinical, economic and policy issues that confront us in modern healthcare. Future Medicine is part of the Future Science Group, an expanding group of independent companies active in the field of scientific information and endeavor.
|
|
|
|
 Press Release - Sex-based medicine |
| Personalized medicine set to impact justice system |
| Press Release - Impact Factors |
| Special Focus Issue on Human iPS Cells |
| Anti-Aging Hormones |
| Reversal of aging shown in human stem cells |
| Oral immunotherapy effective in fighting TB |
| Imaging in Medicine - New medical imaging title |
| Interventional Cardiology - New journal launch |
 |
|
Now on MEDLINE...
Access to Biomarkers in Medicine is available via a free 30-day online trial.
To apply for your free trial please email info@futuremedicine.com quoting reference BMM0310 to obtain password access.
Click here for more information
|
 |
|
Interventional Cardiology charts the advances of this vibrant and dynamic subspecialty and provides a unique resource for interventionalists seeking to keep pace with the unfolding technologies.
|
|
Epigenomics promises to elucidate the inner workings of the genome. Numerous strategies have emerged to detect large numbers of DNA methylation variations and chromatin modifications – two mechanisms that are at the core of epigenomic research. Epigenomics provides a bimonthly forum to address the significant progress in this rapidly expanding research field. |
|
This new journal provides highly structured commentary and analysis regarding advanced imaging technologies and applications. It presents original research findings, publishes comprehensive profiles of imaging techniques, technologies and the materials used in the clinical and drug research settings, and explores risk issues and societal issues associated with medical imaging.
|
|
Immunotherapeutic approaches are now impacting clinical practice, often with outstanding success. Immunotherapy bridges the gap between the medical profession, clinical research and the pharmaceutical industry, providing clinical researchers, drug development specialists, physicians and other healthcare professionals with key information on recent advances in immunotherapy. Immunotherapy is now on EMBASE.
|
|
|
|
|
|
